Four years ago, a study found that cancer has unique microbial signatures that would allow a blood test to diagnose cancer. But in recent months, the study has faced scrutiny for inaccurate data, The Wall Street Journal reported Aug. 30.
The Latest
Asian American and Pacific Islander women once had relatively low rates of breast cancer, but the demographic is now seeing faster-rising rates of cancer compared to other races — and experts are not sure why, CBS News reported Sep. 3.
Houston-based Memorial Hermann Health System is expanding its partnership with on-demand cancer care company Reimagine Care.
The FDA approved afamitresgene autoleucel, or afami-cel (Tecelra), as the first T-cell receptor therapy for cancer.
Adding MRI to digital mammography may prevent more cancer deaths, but it also could contribute to false-positive biopsies, according to a study published Aug. 25 in JAMA Internal Medicine.
President Joe Biden launched the Cancer Moonshot in 2016, when he was serving as vice president in the Obama administration. President Biden reignited the initiative in 2022, setting a goal to reduce the cancer death rate by 50% in the…
Leaders from two top-five cancer centers, as ranked by U.S. News & World Report, shared with Becker's challenges they are facing this year and how they plan to address them.
Coral Gables-based Baptist Health South Florida has named Jenny Waltzer as COO of Baptist Health Cancer Care.
Jeffrey Weber, MD, PhD, a pioneer in cancer immunotherapy and melanoma research, recently died of cancer.
From landmark research investments to peer mentorship programs, here are 20 recent oncology partnerships to know: